Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Rheumatology International
Published in: Rheumatology International 5/2004

01-09-2004 | Original Article

Comparison of serum nitric oxide levels in active juvenile rheumatoid arthritis with those of patients in remission

Authors: Alpana Beri, Surjit Singh, Anju Gupta, Madhu Khullar

Published in: Rheumatology International | Issue 5/2004

Login to get access

Abstract

Thirty-four children with juvenile rheumatoid arthritis were studied for surrogate markers of increased nitric oxide (NO) production by spectrophotometry. Mean levels of reactive nitrogen intermediates and citrulline levels were higher in patients with active disease than in children with partial and complete remission. A significant correlation was also found between clinical indices of inflammation, erythrocyte sedimentation rate, modified Childhood Health Assessment Questionnaire scores, and surrogate markers of increased NO production.
Literature
1.
Cassidy JT (2001) Juvenile rheumatoid arthritis. In: Textbook of pediatric rheumatology, 4th edn. Saunders, Philadelphia, pp 218–321
2.
Wigand R, Meyer J, Busse R, Hecker M (1997) Increased serum NG-hydroxy-L-arginine in patients with rheumatoid arthritis as an index of increased nitric oxide synthase activity. Ann Rheum Dis 56:330–332PubMed
3.
Grabowski PS, England AJ, Dykhuizen R, Copland M, Benjamin N, Reid DM, Ralston SH (1996) Elevated nitric oxide production in rheumatoid arthritis: detection using the fasting urinary nitrate:creatinine ratio. Arthritis Rheum 39:643–647PubMed
4.
Cassidy JT, Levinson JE, Bass JC, Baum J, Brewer EJ Jr, Fink CW, Hanson W, Jacobs JC, Masi AT, Schaller JG et al (1986) A study of classification for diagnosis of juvenile rheumatoid arthritis. Arthritis Rheum 29:274–281PubMed
5.
Singh G, Athreya BH, Fries JF, Goldsmith DA (1994) Measurement of health status in children with juvenile rheumatoid arthritis. Arthritis Rheum 37:1761–1769PubMed
6.
Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR (1982) Analysis of nitrate, nitrite and (15 N) nitrate in biological fluids. Anal Biochem 126:131–138PubMed
7.
Boyde TR, Rahmatullah M (1980) Optimization of conditions for the calorimetric determination of citrulline, using diacetyl-monoxime. Anal Biochem 107:424–431PubMed
8.
Murrell GA, Doland MM, Jang D, Szabo C, Warren RF, Hannafin JA (1996) Nitric oxide: an important articular free radical. J Bone Joint Surg Am 78:265–274PubMed
9.
Moncada S, Higgs A (1993) The L-arginine nitric oxide pathway. N Engl J Med 329:2002–2012PubMed
10.
Ueki Y, Miyake S, Tominaga Y, Eguchi K (1996) Increased nitric oxide levels in patients with rheumatoid arthritis. J Rheumatol 23:230–236PubMed
11.
Wanchu A, Khullar M, Deodhar SD, Bambery P, Sud A (1998) Nitric oxide synthesis is increased in patients with systemic lupus erythematosus. Rheumatol Int 18:41–43CrossRefPubMed
12.
Wanchu A, Agnihotri N, Deodhar SD, Ganguly NK (1996) Plasma reactive nitrogen intermediate levels in patients with clinically active rheumatoid arthritis. Indian J Med Res 104:263–268PubMed
13.
Sud A, Khullar M, Wanchu A, Bambery P (2000) Increased nitric oxide production in patients with systemic sclerosis. Nitric Oxide 4:615–619CrossRefPubMed
14.
Farrell AJ, Blake DR, Palmer RM, Moncada S (1992) Increased concentration of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases. Ann Rheum Dis 51:1219–1222PubMed
15.
Sakurai H, Kohsaka H, Liu MF, Higashiyama H, Hirata Y, Kanno K, Saito I, Miyasaka N (1995) Nitric oxide production and inducible nitric oxide synthase expression in inflammatory arthritides. J Clin Invest 96:2357–2363PubMed
Metadata
Title
Comparison of serum nitric oxide levels in active juvenile rheumatoid arthritis with those of patients in remission
Authors
Alpana Beri
Surjit Singh
Anju Gupta
Madhu Khullar
Publication date
01-09-2004
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 5/2004
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-003-0368-2

Other articles of this Issue 5/2004

Rheumatology International 5/2004 Go to the issue

Case Report

Tuberculous sacroiliitis: a case report

Original Article

Prevalence of atopy in rheumatoid arthritis in Sivas, Turkey. A prospective clinical study

Original Article

Expression of matrix metalloproteinases in vasculitic neuropathy

Original Article

Bone cysts in sarcoidosis: what is their clinical significance?

Case Report

Reversible sclerotic changes of lumbar spine and femur due to long-term oral isotretinoin therapy

Case Report

Reversible dementia in systemic lupus erythematosus without antiphospholipid antibodies or cerebral infarction
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits